Terms: = Germ cell tumor AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC AND Clinical Outcome
8 results:
1. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature.
Chiang JH; Cheng WS; Hood L; Tian Q
OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786
[TBL] [Abstract] [Full Text] [Related]
2. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract] [Full Text] [Related]
3. Heparanase, trkc and p75NTR: their functional involvement in human medulloblastoma cell invasion.
Sinnappah-Kang ND; Kaiser AJ; Blust BE; Mrak RE; Marchetti D
Int J Oncol; 2005 Sep; 27(3):617-26. PubMed ID: 16077909
[TBL] [Abstract] [Full Text] [Related]
4. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract] [Full Text] [Related]
5. Neurotrophin receptor trkc predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
[TBL] [Abstract] [Full Text] [Related]
6. trkc expression predicts good clinical outcome in primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Fung K; Biegel JA; Sutton LN; Rorke LB; Zhao H; Cnaan A; Phillips PC; Lee VM; Trojanowski JQ
J Clin Oncol; 2000 Mar; 18(5):1027-35. PubMed ID: 10694553
[TBL] [Abstract] [Full Text] [Related]
7. Activation of neurotrophin-3 receptor trkc induces apoptosis in medulloblastomas.
Kim JY; Sutton ME; Lu DJ; Cho TA; Goumnerova LC; Goritchenko L; Kaufman JR; Lam KK; Billet AL; Tarbell NJ; Wu J; Allen JC; Stiles CD; Segal RA; Pomeroy SL
Cancer Res; 1999 Feb; 59(3):711-9. PubMed ID: 9973222
[TBL] [Abstract] [Full Text] [Related]
8. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
[TBL] [Abstract] [Full Text] [Related]
